Evidence map›Paper›PMID 39658047›Full record

ArticleNucleic acids research2025

High throughput variant libraries and machine learning yield design rules for retron gene editors.

Kate D Crawford, Asim G Khan, Santiago C Lopez, Hani Goodarzi, Seth L Shipman

Abstract read
In one paragraph

Article in Nucleic acids research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Kate D CrawfordGladstone Institute of Data Science and Biotechnology, 1650 Owens St, San Francisco, CA 94158, USA.
Asim G KhanGladstone Institute of Data Science and Biotechnology, 1650 Owens St, San Francisco, CA 94158, USA.
Santiago C LopezGladstone Institute of Data Science and Biotechnology, 1650 Owens St, San Francisco, CA 94158, USA.
Hani GoodarziArc Institute, 3181 Porter Dr, Palo Alto, CA 94304, USA.
Seth L ShipmanGladstone Institute of Data Science and Biotechnology, 1650 Owens St, San Francisco, CA 94158, USA.ORCID 0000-0003-3130-8043

Funding

RetroDecoys: Temporally-regulated and cell type selective technology for transcriptional controlR21EB031393 · NIBIB · J. DAVID GLADSTONE INSTITUTES · PI SHIPMAN, SETH LAWLER · 2022 to 2023
$520k
Gary and Eileen Morgenthaler FundNational Science Foundation MCB 2137692NIBIB NIH HHS R21 EB031393NIBIB NIH HHS R21EB031393Pew Biomedical Scholars ProgramUCSF Discovery Fellows ProgramW. M. Keck Foundation
6 · The paper itself

Abstract

The bacterial retron reverse transcriptase system has served as an intracellular factory for single-stranded DNA in many biotechnological applications. In these technologies, a natural retron non-coding RNA (ncRNA) is modified to encode a template for the production of custom DNA sequences by reverse transcription. The efficiency of reverse transcription is a major limiting step for retron technologies, but we lack systematic knowledge of how to improve or maintain reverse transcription efficiency while changing the retron sequence for custom DNA production. Here, we test thousands of different modifications to the Retron-Eco1 ncRNA and measure DNA production in pooled variant library experiments, identifying regions of the ncRNA that are tolerant and intolerant to modification. We apply this new information to a specific application: the use of the retron to produce a precise genome editing donor in combination with a CRISPR-Cas9 RNA-guided nuclease (an editron). We use high-throughput libraries in Saccharomyces cerevisiae to additionally define design rules for editrons. We extend our new knowledge of retron DNA production and editron design rules to human genome editing to achieve the highest efficiency Retron-Eco1 editrons to date.

Indexed as

Gene EditingMachine LearningCRISPR-Cas SystemsGene LibraryRNA, Guide, CRISPR-Cas SystemsRNA, UntranslatedSaccharomyces cerevisiaeRNA, Guide, CRISPR-Cas SystemsRNA, Untranslated

Identifiers

PMID39658047
PMCPMC11754653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.